Éric Farfour
- Microbiology top 2%
-
- Antibiotic Use and Resistance 6
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 12
- Endocrinology top 5%
- Enterobacteriaceae and Cronobacter Research 4
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 14
-
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 detection and testing 5
- SARS-CoV-2 and COVID-19 Research 4
-
- Respiratory viral infections research 8
- Co-authors
- Marc VasseCatherine SettegranaFrédéric CharlottePierre BuffetMakoto MiyaraPhilippe LespritTiffany PascreauLaurent Dortet
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (6 papers)Diagnostic Microbiology and Infectious Disease (4 papers)Journal of Clinical Medicine (3 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Éric Farfour
58 papers receiving 591 citations
Peers
Comparison fields: 5 of 86
- Microbiology 43
- Applied Microbiology and Biotechnology 58
- Molecular Medicine 95
- Endocrinology 93
- Clinical Biochemistry 105
Countries citing papers authored by Éric Farfour
This map shows the geographic impact of Éric Farfour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Farfour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Farfour more than expected).
Fields of papers citing papers by Éric Farfour
This network shows the impact of papers produced by Éric Farfour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Farfour. The network helps show where Éric Farfour may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Éric Farfour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 8 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 11 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 49 | |
| 16 | 2020 | 7 | |
| 17 | 2019 | 2 | |
| 18 | 2012 | 17 | |
| 19 | 2012 | 77 | |
| 20 | 2010 | 6 |
About Éric Farfour
Éric Farfour is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Endocrinology and Infectious Diseases, having authored 63 papers that have together received 604 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (14 papers), Antibiotic Resistance in Bacteria (12 papers), COVID-19 Clinical Research Studies (8 papers), Respiratory viral infections research (8 papers), Antibiotic Use and Resistance (6 papers), SARS-CoV-2 detection and testing (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Enterobacteriaceae and Cronobacter Research (4 papers). The work is most often cited by research in Microbiology (43 citations), Applied Microbiology and Biotechnology (58 citations), Molecular Medicine (95 citations), Endocrinology (93 citations) and Clinical Biochemistry (105 citations). Éric Farfour has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Marc Vasse, Catherine Settegrana, Frédéric Charlotte, Pierre Buffet, Makoto Miyara, Philippe Lesprit, Tiffany Pascreau, Laurent Dortet, Nicole Guiso and Sophie Guillot. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Diagnostic Microbiology and Infectious Disease, Journal of Clinical Medicine, Journal of Hospital Infection and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.